– Company to host live webcast and conference call Monday, December 15, 2025 at 8:00 am ET –EMERYVILLE, Calif., Dec. 14, 2025 -- Kyverna Therapeutics, Inc. , a clinical-stage biopharmaceutical...
Kyverna Therapeutics to Report Topline Results from Registrational Phase 2 KYSA-8 Trial of KYV-101 in Stiff Person Syndrome
